Systems and methods for extraction and cryopreservation of bone marrow
Inventors
Woods, Erik J. • Johnstone, Brian H. • GU, Dongsheng • Sherry, Aubrey Marie • Musall, Kelsey Gwen
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods, systems, and compositions are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation, and for obtaining desired cells from cryopreserved and fresh bone marrow.
Core Innovation
The method processes a biological sample comprising cells by generating a transplantable unit and a smaller surrogate unit whose cell concentrations differ by no more than 30%. Both units are cooled at a common optimized rate that balances damage from intracellular ice formation with damage from extracellular ice formation. Storing both units in the same long-term storage container under similar conditions allows the surrogate unit to accurately represent the transplantable unit.
The method provides equivalent survival and viability for cells from both units, including a post-thaw cell proliferation rate in the surrogate unit that differs by no more than 30% from that of the transplantable unit. Post-thaw comparisons between surrogate vials and cryopreservation bags report no systematic viability difference to support using vials as surrogates. Experimental arrangements relate cooling and ischemia conditions to cell viability and colony-forming unit counts across representative cryopreserved units.
Claims Coverage
The claims identify one independent claim, claim 1, comprising four inventive features governing the generation, cooling, and storage of a surrogate unit that reflects a transplantable unit.
Generation of transplantable and surrogate units
The method generates a transplantable unit having a first volume and first cell concentration, and a smaller surrogate unit having a second volume less than the first volume, from a biological sample comprising cells.
Surrogate unit cell concentration parameters
The surrogate unit is generated such that its second cell concentration differs by no more than 30% from the first cell concentration of the transplantable unit.
Common optimized cooling rate
Cells of both the transplantable unit and the surrogate unit are cooled at a common optimized rate that balances damage from intracellular ice formation with damage from extracellular ice formation.
Shared long-term storage and comparable post-thaw performance
Both units are stored in the same long-term storage container to expose their cells to similar conditions, providing equivalent cell survival, viability, and a surrogate post-thaw proliferation rate differing by no more than 30% from that of the transplantable unit so that the surrogate unit accurately represents the transplantable unit.
In summary, independent claim 1 covers generating a smaller surrogate unit with a cell concentration within 30% of the transplantable unit, cooling both units at a common optimized rate, and storing both in the same container to achieve equivalent post-thaw survival, viability, and proliferation.
Stated Advantages
The surrogate unit provides equivalent cell survival and viability and has a post-thaw cell proliferation rate differing by no more than 30% from that of the transplantable unit, allowing it to accurately represent the transplantable unit.
Documented Applications
Processing and cryopreservation of biological samples comprising cells, such as hematopoietic stem cells, mesenchymal stem cells, or cadaveric vertebral-bone marrow, to generate transplantable and surrogate units for long-term storage.
Use of the surrogate unit as a proxy for the transplantable unit when assessing post-thaw cell survival, viability, and proliferation without thawing or handling the transplantable product.
Interested in licensing this patent?